DK442779A - Fremgangsmaade til fremstilling af diphenylbutylpiperazincarboxamider - Google Patents

Fremgangsmaade til fremstilling af diphenylbutylpiperazincarboxamider

Info

Publication number: DK442779A
Authority: DK; Denmark
Prior art keywords: butyl piperazine; piperazine carboxamides; preparing diphenyl; diphenyl butyl; preparing
Prior art date: 1978-10-20

Application number

DK442779A

Other languages

English (en)

Other versions

DK149057B (da

DK149057C (da

Inventor

A K K Bjoerk

K G Olsson

A L Abramo

E G Christensson

Original Assignee

Ferrosan Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-10-20

Filing date

1979-10-19

Publication date

1980-04-21

1979-10-19 Application filed by Ferrosan Ab filed Critical Ferrosan Ab

1980-04-21 Publication of DK442779A publication Critical patent/DK442779A/da

1986-01-06 Publication of DK149057B publication Critical patent/DK149057B/da

1986-06-02 Application granted granted Critical

1986-06-02 Publication of DK149057C publication Critical patent/DK149057C/da

Links

-1 DIPHENYL BUTYL PIPERAZINE CARBOXAMIDES Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/194—Radicals derived from thio- or thiono carboxylic acids
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L1/00—Enclosures; Chambers
- B01L1/52—Transportable laboratories; Field kits

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

DK442779A 1978-10-20 1979-10-19 Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-piperazincarboxamider eller -carbothioamider eller syreadditionssalte deraf DK149057C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE7810971		1978-10-20
SE7810971		1978-10-20

Publications (3)

Publication Number	Publication Date
DK442779A true DK442779A (da)	1980-04-21
DK149057B DK149057B (da)	1986-01-06
DK149057C DK149057C (da)	1986-06-02

Family

ID=20336152

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK442779A DK149057C (da)	1978-10-20	1979-10-19	Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-piperazincarboxamider eller -carbothioamider eller syreadditionssalte deraf

Country Status (21)

Country	Link
US (3)	US4308387A (da)
JP (1)	JPS5557572A (da)
AT (1)	AT376666B (da)
AU (1)	AU529260B2 (da)
BE (1)	BE879528A (da)
CA (1)	CA1130807A (da)
CH (1)	CH643247A5 (da)
DE (1)	DE2941880A1 (da)
DK (1)	DK149057C (da)
ES (1)	ES485188A1 (da)
FI (1)	FI73986C (da)
FR (1)	FR2439187A1 (da)
GB (1)	GB2037745B (da)
HK (1)	HK57184A (da)
IT (1)	IT1207269B (da)
LU (1)	LU81807A1 (da)
NL (2)	NL190160C (da)
NO (1)	NO154582C (da)
NZ (1)	NZ191867A (da)
SE (1)	SE448730B (da)
SG (1)	SG7384G (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE791501A (fr) *	1971-11-19	1973-05-17	Albert Ag Chem Werke	Diamines cycliques n,n'-disubstituees et leur procede de preparation
EP0042366B1 (en) *	1980-06-16	1984-11-07	AB Ferrosan	Diphenylbutyl-1-acylpiperazines
ATE28327T1 (de) *	1981-12-02	1987-08-15	Ferrosan Ab	1-piperazinocarboxylate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4543352A (en) *	1983-04-29	1985-09-24	William H. Rorer, Inc.	Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
AT387572B (de) *	1983-05-20	1989-02-10	Ferrosan Ab	Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
ES524680A0 (es)	1983-08-02	1984-12-16	Espanola Farma Therapeut	Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
SE8304361D0 (sv) *	1983-08-10	1983-08-10	Ferrosan Ab	Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
FR2558162B1 (fr) *	1984-01-17	1986-04-25	Adir	Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE8500573D0 (sv) *	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4960776A (en) *	1987-01-28	1990-10-02	A. H. Robins Company, Inc.	4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
WO1990013539A1 (fr) *	1989-04-28	1990-11-15	Meiji Seika Kaisha, Ltd.	Nouveaux derives de piperazine a substitution n et medicament de traitement des troubles fonctionnels du cerveau
FR2673182A1 (fr) *	1991-02-22	1992-08-28	Univ Caen	Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
SE9100860D0 (sv) *	1991-03-22	1991-03-22	Kabi Pharmacia Ab	New use
SE9201239D0 (sv) *	1992-04-21	1992-04-21	Kabi Pharmacia Ab	Agents for treating substance abuse disorders
DE4219973A1 (de) *	1992-06-19	1993-12-23	Basf Ag	N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SE9202266D0 (sv) *	1992-07-31	1992-07-31	Kabi Pharmacia Ab	Novel piperazine carboxamides
DE4307181C1 (de) *	1993-03-08	1994-11-10	Dresden Arzneimittel	Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE4341403A1 (de) *	1993-12-04	1995-06-08	Basf Ag	N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
DE29815747U1 (de)	1998-09-02	2000-01-05	Ramsauer, Dieter, 42555 Velbert	Anschraubscharnier mit Raststellung
GB9923748D0 (en) *	1999-10-07	1999-12-08	Glaxo Group Ltd	Chemical compounds
USRE39921E1 (en)	1999-10-07	2007-11-13	Smithkline Beecham Corporation	Chemical compounds
GB0025354D0 (en) *	2000-10-17	2000-11-29	Glaxo Group Ltd	Chemical compounds
GB0108594D0 (en) *	2001-04-05	2001-05-23	Glaxo Group Ltd	Chemical compounds
US7842307B2 (en) *	2001-08-06	2010-11-30	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
US7157103B2 (en)	2001-08-06	2007-01-02	Euro-Celtique S.A.	Pharmaceutical formulation containing irritant
US20030044458A1 (en) *	2001-08-06	2003-03-06	Curtis Wright	Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030068375A1 (en)	2001-08-06	2003-04-10	Curtis Wright	Pharmaceutical formulation containing gelling agent
US7141250B2 (en) *	2001-08-06	2006-11-28	Euro-Celtique S.A.	Pharmaceutical formulation containing bittering agent
US7332182B2 (en)	2001-08-06	2008-02-19	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
GB0203022D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
WO2003066589A1 (en) *	2002-02-08	2003-08-14	Glaxo Group Limited	Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0203020D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
CA2916869A1 (en)	2004-06-12	2005-12-29	Jane C. Hirsh	Abuse-deterrent drug formulations
JP4823673B2 (ja) *	2005-12-15	2011-11-24	タカラベルモント株式会社	ショックレス弁を接続した油圧回路
JP2010169206A (ja) *	2009-01-23	2010-08-05	Finesinter Co Ltd	ノンリークショックレス電磁比例制御弁
US10668060B2 (en)	2009-12-10	2020-06-02	Collegium Pharmaceutical, Inc.	Tamper-resistant pharmaceutical compositions of opioids and other drugs
ME02874B (me)	2010-12-22	2018-04-20	Purdue Pharma Lp	Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu
PH12013501345A1 (en)	2010-12-23	2022-10-24	Purdue Pharma Lp	Tamper resistant solid oral dosage forms
MX2015010041A (es)	2013-02-05	2015-10-30	Purdue Pharma Lp	Formulacion farmaceuticas resistentes a la alteracion.
US10751287B2 (en)	2013-03-15	2020-08-25	Purdue Pharma L.P.	Tamper resistant pharmaceutical formulations
US9737530B1 (en)	2016-06-23	2017-08-22	Collegium Pharmaceutical, Inc.	Process of making stable abuse-deterrent oral formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL137318C (da) *	1964-06-09
JPS518283A (en) *	1974-07-09	1976-01-23	Kyorin Seiyaku Kk	11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) *	1976-10-07	1978-04-27	Kyorin Seiyaku Kk	Piperadine derivative

1979
- 1979-10-15 NO NO793315A patent/NO154582C/no unknown
- 1979-10-16 DE DE19792941880 patent/DE2941880A1/de active Granted
- 1979-10-18 CH CH938379A patent/CH643247A5/de not_active IP Right Cessation
- 1979-10-18 FR FR7925953A patent/FR2439187A1/fr active Granted
- 1979-10-18 IT IT7926603A patent/IT1207269B/it active Protection Beyond IP Right Term
- 1979-10-18 FI FI793238A patent/FI73986C/fi not_active IP Right Cessation
- 1979-10-18 US US06/086,068 patent/US4308387A/en not_active Expired - Lifetime
- 1979-10-19 SE SE7908701A patent/SE448730B/sv not_active IP Right Cessation
- 1979-10-19 LU LU81807A patent/LU81807A1/de unknown
- 1979-10-19 GB GB7936297A patent/GB2037745B/en not_active Expired
- 1979-10-19 JP JP13581779A patent/JPS5557572A/ja active Granted
- 1979-10-19 NL NLAANVRAGE7907741,A patent/NL190160C/xx not_active IP Right Cessation
- 1979-10-19 NZ NZ191867A patent/NZ191867A/xx unknown
- 1979-10-19 AU AU51984/79A patent/AU529260B2/en not_active Expired
- 1979-10-19 CA CA338,084A patent/CA1130807A/en not_active Expired
- 1979-10-19 ES ES485188A patent/ES485188A1/es not_active Expired
- 1979-10-19 DK DK442779A patent/DK149057C/da not_active IP Right Cessation
- 1979-10-19 BE BE0/197737A patent/BE879528A/fr not_active IP Right Cessation
- 1979-10-19 AT AT0683479A patent/AT376666B/de not_active IP Right Cessation
1981
- 1981-01-23 US US06/227,690 patent/US4385057A/en not_active Expired - Lifetime
1982
- 1982-09-15 US US06/418,685 patent/US4447433A/en not_active Expired - Lifetime
1984
- 1984-01-26 SG SG73/84A patent/SG7384G/en unknown
- 1984-07-26 HK HK571/84A patent/HK57184A/xx not_active IP Right Cessation
1994
- 1994-03-23 NL NL940004C patent/NL940004I1/nl unknown

Also Published As

Publication number	Publication date
GB2037745B (en)	1982-11-24
NL190160B (nl)	1993-06-16
NL7907741A (nl)	1980-04-22
NL190160C (nl)	1993-11-16
HK57184A (en)	1984-08-03
AU529260B2 (en)	1983-06-02
CA1130807A (en)	1982-08-31
LU81807A1 (de)	1980-01-25
JPS6326756B2 (da)	1988-05-31
US4308387A (en)	1981-12-29
US4447433A (en)	1984-05-08
DK149057B (da)	1986-01-06
IT7926603A0 (it)	1979-10-18
FR2439187A1 (fr)	1980-05-16
DE2941880A1 (de)	1980-04-30
SE448730B (sv)	1987-03-16
DE2941880C2 (da)	1989-04-20
BE879528A (fr)	1980-04-21
AU5198479A (en)	1980-06-19
NL940004I1 (nl)	1994-05-02
NZ191867A (en)	1983-06-14
GB2037745A (en)	1980-07-16
IT1207269B (it)	1989-05-17
FI73986C (fi)	1987-12-10
NO154582C (no)	1986-11-05
DK149057C (da)	1986-06-02
ES485188A1 (es)	1980-05-16
US4385057A (en)	1983-05-24
NO793315L (no)	1980-04-22
JPS5557572A (en)	1980-04-28
SE7908701L (sv)	1980-04-21
AT376666B (de)	1984-12-27
NO154582B (no)	1986-07-28
FI73986B (fi)	1987-08-31
CH643247A5 (de)	1984-05-30
ATA683479A (de)	1984-05-15
FI793238A7 (fi)	1980-04-21
SG7384G (en)	1985-02-08
FR2439187B1 (da)	1983-03-18

Legal Events

Date	Code	Title	Description
1999-12-06	PUP	Patent expired

Publication	Publication Date	Title
DK442779A (da)	1980-04-21	Fremgangsmaade til fremstilling af diphenylbutylpiperazincarboxamider
DK364579A (da)	1980-03-01	Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK147912C (da)	1985-06-17	Fremgangsmaade til fremstilling af 1alfa-hydroxylerede vitamin d-forbindelser
DK42480A (da)	1980-08-06	Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK149023C (da)	1986-10-13	Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK280182A (da)	1982-12-24	Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
ES490172A0 (es)	1981-02-16	Metodo para preparar nuevas espiro (dihidrobenzofuran-pipe- ridinas y -pirrolidinas)
DK7579A (da)	1979-07-10	Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK19579A (da)	1979-07-19	Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK364880A (da)	1981-03-01	Fremgangsmaade til fremstilling af 6-pyridinyl-3-(2h)-pyridazioner
DK157009C (da)	1990-03-26	Fremgangsmaade til fremstilling af 1-(3-mercapto-2s-methylpropionyl)-pyrrolidin-2s-carboxylsyre
DK447380A (da)	1981-04-24	Fremgangsmaade til fremstilling af d3-vitaminforbindelser
DK150479C (da)	1987-10-26	Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK165687C (da)	1993-06-07	Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK141581C (da)	1980-10-06	Fremgangsmaade til fremstilling af alkyl- eller arylthiomethylphenoler
DK370582A (da)	1983-02-20	Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK330279A (da)	1980-02-17	Fremgangsmaade til fremstilling af soem
DK143340C (da)	1981-12-14	Fremgangsmaade til fremstilling af 2-(4-furoylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoliner
DK454579A (da)	1980-04-28	Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK123480A (da)	1980-09-23	Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK444279A (da)	1980-04-24	Fremgangsmaade til fremstilling af 6-hydroxymethyl-2-(beta-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylsyre
DK154554C (da)	1989-04-17	Fremgangsmaade til fremstilling af alfa-methyl-carbazol-2-eddikesyrederivater
DK144677C (da)	1982-11-29	Fremgangsmaade til fremstilling af dl-phenylglycinamid
DK145741C (da)	1983-08-01	Fremgangsmaade til fremstilling af 6-chlor-alfa-methyl-carbazol-2-eddikesyre
DK157847C (da)	1990-09-17	Fremgangsmaade til fremstilling af pyrrolidin-2-oner